Janney Montgomery Scott
XLRN

Janney Montgomery Scott’s Acceleron Pharma XLRN Stock Holding History

Janney Montgomery Scott’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,029
Closed -$349K – 2469
2021
Q3 		$349K Buy
2,029
+105
+5% +$13.7K ﹤0.01% 1880
2021
Q2 		$241K Sell
1,924
-4,375
-69% -$552K ﹤0.01% 2036
2021
Q1 		$854K Sell
6,299
-132
-2% -$17.1K ﹤0.01% 1277
2020
Q4 		$823K Hold
6,431
– – ﹤0.01% 1278
2020
Q3 		$724K Sell
6,431
-48
-0.7% -$4.78K ﹤0.01% 1243
2020
Q2 		$617K Buy
6,479
+1,973
+44% +$190K ﹤0.01% 1264
2020
Q1 		$405K Buy
+4,506
New +$350K ﹤0.01% 1340
2016
Q2 		– Sell
-8,350
Closed -$220K – 1241
2016
Q1 		$220K Buy
8,350
+677
+9% +$19.7K 0.01% 1100
2015
Q4 		$374K Sell
7,673
-2,477
-24% -$89.1K 0.01% 946
2015
Q3 		$253K Buy
10,150
+1,200
+13% +$36.1K 0.01% 1134
2015
Q2 		$283K Buy
8,950
+2,245
+33% +$72.4K 0.01% 1532
2015
Q1 		$255K Buy
+6,705
New +$267K ﹤0.01% 1892

Janney Montgomery Scott's XLRN Position: Q4 2021 in Review

Janney Montgomery Scott sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 2,029 shares — an estimated $349K sold.

Janney Montgomery Scott first reported a position in XLRN in Q1 2015 and held it in 12 quarters. The position peaked at $854K in Q1 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Janney Montgomery Scott reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Janney Montgomery Scott sold 2,029 Acceleron Pharma shares in Q4 2021, an estimated $349K.
  • Janney Montgomery Scott first reported a position in Acceleron Pharma in Q1 2015 and held it in 12 quarters.
  • Janney Montgomery Scott's Acceleron Pharma position peaked at $854K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Janney Montgomery Scott's 13F filing for Q4 2021, filed 27 Jan 2022.